Chet Kwon
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Cell Adhesion Molecules Research, Chemical Synthesis and Analysis, Glycosylation and Glycoproteins Research, Protease and Inhibitor Mechanisms, Peptidase Inhibition and Analysis
Most-Cited Works
- → Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)(2002)309 cited
- → Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic(1999)116 cited
- → Discovery of Potent Nonpeptide Vitronectin Receptor (αVβ3) Antagonists(1997)114 cited
- → Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists(1996)72 cited
- → Combinatorial chemistry. Use of an intramolecular ruthenium catalyzed olefin/alkyne metathesis reaction in tandem with a Diels-Alder cycloaddition reaction to construct functionalized hexahydroisoindoles(1998)51 cited
- → Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist(1995)49 cited
- → Structure−Activity Relationships of Novel Hematoregulatory Peptides(1996)36 cited
- → Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics(1999)30 cited
- → Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists(2003)27 cited
- → Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors(2007)26 cited